METHYLPREDNISOLONE 40 MG/ML VL
METHYLPREDNISOLONE 40 MG/ML VL, a generic anti-inflammatory steroid with an acquisition cost of $8.36, typically shows substantial pricing variation between acquisition cost and hospital billing rates.
About the analyst
Kevin Nyk analyzes hospital pricing data at BillRazor Research. He specializes in Medicare reimbursement patterns and chargemaster pricing across U.S. hospitals. Expertise: hospital pricing, Medicare rates, chargemaster analysis.
Methylprednisolone is a corticosteroid injection used to treat inflammatory conditions such as arthritis, allergic reactions, and autoimmune disorders. This generic formulation typically has lower acquisition costs compared to brand-name alternatives, affecting pharmacy reimbursement calculations.
No credit card required. Results in 60 seconds.
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.